Filing Details

Accession Number:
0001209191-17-065201
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-12 16:23:59
Reporting Period:
2017-12-08
Accepted Time:
2017-12-12 16:23:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267565 Collegium Pharmaceutical Inc COLL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1619884 David Hirsch C/O Longitude Capital Partners,Llc
2740 Sand Hill Road, 2Nd Floor
Menlo Park CA 94025
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-12-08 980,350 $17.34 2,276,222 No 4 S Indirect By LVP
Common Stock Disposition 2017-12-08 19,650 $17.34 45,620 No 4 S Indirect By LCA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By LVP
No 4 S Indirect By LCA
Footnotes
  1. Following the transactions reported herein, the reporting person has ceased to be the direct or indirect beneficial owner of more than 10% of any class of the Issuer's equity securities.
  2. Reflects securities held by Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Associates, L.P. ("LCA"). Longitude Capital Partners, LLC ("LCP") is the general partner of LVP and LCA. The reporting person is a member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. The reporting person disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of his pecuniary interest therein.